Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02880163 · ClinicalTrials.gov registry record · NA

REVIVE: Reducing Exsanguination Via In-Vivo Expandable Foam

A NA study of Trauma and Hemorrhagic Shock, sponsored by Arsenal Medical.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
2
Study locations

NCT02880163 is a NA study of Trauma and Hemorrhagic Shock that is actively recruiting participants, run by Arsenal Medical. The registered enrollment target is 40 participants, below the 307-participant average among 56 other Trauma trials with a reported enrollment target (87% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02880163, a NA study of Trauma and Hemorrhagic Shock, is actively recruiting participants, sponsored by Arsenal Medical.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to demonstrate safety, effectiveness and benefit-risk profile of ResQFoam for the inhospital treatment of exsanguinating, intraabdominal haemorrhage due to trauma in patients where emergent laparotomy is required.

Conditions Studied

Trauma Hemorrhagic Shock Exsanguinating Hemorrhage Shock; Traumatic

Interventions

  • DEVICE ResQFoam

Study Locations (2)

Alabama

  • University of Alabama at Birmingham - Birmingham

Ohio

  • University of Cincinnati - Cincinnati

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-08-07
Est. Completion 2026-12-31
Phase NA

Sponsor

Arsenal Medical

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02880163

The ClinicalTrials.gov registry entry for NCT02880163 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 307-participant average among 56 other Trauma trials with a reported enrollment target (87% lower). The listed sponsor is Arsenal Medical, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Trauma appearing as the primary indexed condition, and to 1 intervention - of which ResQFoam is the first listed.

NCT02880163 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Alabama, Ohio.

Frequently Asked Questions

What is clinical trial NCT02880163 about?

NCT02880163 is a clinical study titled "REVIVE: Reducing Exsanguination Via In-Vivo Expandable Foam". The purpose of this study is to demonstrate safety, effectiveness and benefit-risk profile of ResQFoam for the inhospital treatment of exsanguinating, intraabdominal haemorrhage due to trauma in patients where emergent laparotomy is required.

What is the current status of trial NCT02880163?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-08-07. Estimated completion is 2026-12-31.

What conditions does trial NCT02880163 study?

This clinical trial studies the following conditions: Trauma, Hemorrhagic Shock, Exsanguinating Hemorrhage, Shock; Traumatic.

What interventions are being tested in trial NCT02880163?

The interventions under investigation include: ResQFoam (DEVICE).

Who is sponsoring clinical trial NCT02880163?

This trial is sponsored by Arsenal Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02880163 being conducted?

This trial has 2 study locations across Alabama, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Trauma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Trauma

All registered trials for this condition

Hemorrhagic Shock

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.